Skip to main content
 (0)
←Back to all technologies

Antibody for Tubulointerstitial Nephritis Antigen

For licensing information, contact:
Colleen King, Fellowship (Internally Funded)
847-491-2163
colleen.king@northwestern.edu
For Information, Contact:
Ashley Block
Post Licensing Manager Northwestern University
Innovation & New Ventures Office 847-467-2225 INVOLicenseCompliance@northwestern.edu

NU 2008-136 

 

Inventors

Yashpal Kanwar* 

Ping Xie 

 

Short Description

Identification of species-specific epitopes for generating antibodies against tubulointerstitial nephritis antigen (TINag)

 

Abstract

Northwestern researchers have developed a method for production of species-specific tubulointerstitial antigen (TINag) antibodies. Tubulointerstitial kidney disorders are known to develop due to the presence of TINag, which stimulates production of auto-reactive antibodies. If TINag antibodies are produced, the disease progresses rapidly, leading to kidney failure. Therefore, study of TINag and TINag specific antibodies is a crucial step to understanding severe kidney disease and discovering therapies against it. Until the development of this innovative method by Prof. Kanwar and colleagues, TINag antibody production was a cumbersome and labor-intensive process. This TINag antibody production method could accelerate the pace of kidney disease research enabling development of therapeutics in the future. 

 

Applications

  • Clinical and laboratory research of kidney diseases

 

Advantages

  • Easy to produce
  • Species-specific 

 

 

Patent Information: